FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to ophthalmology. It can be used for therapy of partial optic nerve atrophy. For treatment, inhalation is used, heated to 45° HeliOx gas mixture containing 79% helium and 21% oxygen. Inhalations are carried out in a cyclic fractional mode for 5 days, 1 session daily. Each session consists of 3 cycles. Also, drug therapy is performed for 10 days.
EFFECT: method enables improving vision indices in patients.
1 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF COMBINED TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY | 2010 |
|
RU2472475C2 |
METHOD OF TREATING VISUAL NERVE AND RETINAL DISEASES | 2010 |
|
RU2447864C1 |
METHOD FOR TREATING GLAUCOMATOUS NEUROPATHY | 2006 |
|
RU2308916C1 |
METHOD OF TREATING INVOLUTIONAL EYE DISEASES | 2011 |
|
RU2565840C2 |
METHOD OF TREATING PATIENTS SUFFERING PRIMARY OPEN-ANGLE GLAUCOMA | 2012 |
|
RU2506062C1 |
METHOD OF TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY | 2015 |
|
RU2578953C1 |
METHOD OF TREATING DISEASES OF OPTIC NERVE AND RETINA | 2008 |
|
RU2373904C1 |
METHOD FOR THE ETIOPATHOGENETIC TREATMENT OF PARAVASAL DISORDERS OF BULBAR CONJUNCTIVA IN PATIENTS WITH COVID-19 ASSOCIATED PNEUMONIA | 2021 |
|
RU2760297C1 |
METHOD OF TREATING DISEASES OF OPTIC NERVE AND RETINA | 2012 |
|
RU2500370C1 |
METHOD OF TREATING CATARACT IN PATIENTS WITH DYSTROPHIC RETINAL DISEASES | 2009 |
|
RU2403894C1 |
Authors
Dates
2025-04-25—Published
2024-03-20—Filed